2022 Q4 Form 10-K Financial Statement

#000151597123000048 Filed on April 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021
Revenue $4.792M $20.02M $12.83M
YoY Change 22.39% 56.01% 37.14%
Cost Of Revenue $2.803M $15.03M $7.105M
YoY Change 29.86% 111.58% 22.01%
Gross Profit $1.989M $4.990M $5.729M
YoY Change 13.21% -12.91% 62.06%
Gross Profit Margin 41.5% 24.92% 44.64%
Selling, General & Admin $2.316M $7.386M $4.258M
YoY Change 52.33% 73.45% 39.27%
% of Gross Profit 116.48% 148.02% 74.32%
Research & Development $146.4K
YoY Change
% of Gross Profit 2.93%
Depreciation & Amortization $3.090K $12.35K $833.0K
YoY Change -98.39% -98.52% -0.59%
% of Gross Profit 0.16% 0.25% 14.54%
Operating Expenses $2.074M $7.544M $5.091M
YoY Change 21.07% 48.19% 30.69%
Operating Profit -$85.30K -$2.555M $638.3K
YoY Change -296.05% -500.21% -277.31%
Interest Expense -$165.9K $399.0K -$15.36K
YoY Change 5374.59% -2697.86% -43.01%
% of Operating Profit -2.41%
Other Income/Expense, Net $167.1K -$397.7K $0.00
YoY Change 8.31% -100.0%
Pretax Income -$84.04K -$2.952M $623.0K
YoY Change -143.14% -573.9% 161.08%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$84.04K -$2.952M $623.0K
YoY Change -143.14% -573.9% 161.08%
Net Earnings / Revenue -1.75% -14.74% 4.85%
Basic Earnings Per Share -$0.07 $0.02
Diluted Earnings Per Share $0.00 -$0.07 $14.52K
COMMON SHARES
Basic Shares Outstanding 42.24M shares 41.86M shares 40.91M shares
Diluted Shares Outstanding 41.86M shares 42.89M shares

Balance Sheet

Concept 2022 Q4 2022 2021
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.056M $2.056M $932.8K
YoY Change 120.37% 120.37% 30.42%
Cash & Equivalents $2.056M $2.056M $932.8K
Short-Term Investments
Other Short-Term Assets $164.00 $61.40K $79.63K
YoY Change 0.0% -22.89% 3010.55%
Inventory $526.3K $526.3K $566.8K
Prepaid Expenses $61.24K
Receivables $1.510M $1.510M $1.275M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $4.153M $4.153M $2.854M
YoY Change 45.54% 45.54% 143.86%
LONG-TERM ASSETS
Property, Plant & Equipment $36.54K $36.54K $48.89K
YoY Change -25.26% -25.26% -38.56%
Goodwill
YoY Change
Intangibles $1.188M
YoY Change 47.06%
Long-Term Investments $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0%
Other Assets $73.88K $73.88K $154.3K
YoY Change -52.12% -52.12% -10.33%
Total Long-Term Assets $1.298M $1.298M $1.021M
YoY Change 27.17% 27.17% -42.28%
TOTAL ASSETS
Total Short-Term Assets $4.153M $4.153M $2.854M
Total Long-Term Assets $1.298M $1.298M $1.021M
Total Assets $5.452M $5.452M $3.875M
YoY Change 40.7% 40.7% 31.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.349M $1.349M $930.5K
YoY Change 44.98% 44.98% -10.75%
Accrued Expenses $118.4K $118.4K $50.67K
YoY Change 133.63% 133.63% -23.6%
Deferred Revenue
YoY Change
Short-Term Debt $3.071M $3.071M $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $4.538M $4.538M $981.1K
YoY Change 362.56% 362.56% -20.94%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $150.0K
YoY Change -100.0% -100.0% 0.0%
Other Long-Term Liabilities $458.2K $458.2K $136.5K
YoY Change 235.82% 235.82% 786.04%
Total Long-Term Liabilities $458.2K $458.2K $286.5K
YoY Change 59.97% 59.97% 73.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.538M $4.538M $981.1K
Total Long-Term Liabilities $458.2K $458.2K $286.5K
Total Liabilities $4.996M $4.996M $1.268M
YoY Change 294.18% 294.18% -9.87%
SHAREHOLDERS EQUITY
Retained Earnings -$8.298M
YoY Change 55.23%
Common Stock $42.24K
YoY Change 1.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $455.4K $455.4K $2.607M
YoY Change
Total Liabilities & Shareholders Equity $5.452M $5.452M $3.875M
YoY Change 40.7% 40.7% 31.84%

Cashflow Statement

Concept 2022 Q4 2022 2021
OPERATING ACTIVITIES
Net Income -$84.04K -$2.952M $623.0K
YoY Change -143.14% -573.9% 161.08%
Depreciation, Depletion And Amortization $3.090K $12.35K $833.0K
YoY Change -98.39% -98.52% -0.59%
Cash From Operating Activities -$215.8K -$1.822M $211.9K
YoY Change -49.18% -959.66% -62.92%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$10.00K
YoY Change -100.0% -7.66%
Acquisitions
YoY Change
Other Investing Activities $10.00K $10.00K
YoY Change
Cash From Investing Activities $10.00K $10.00K -$10.00K
YoY Change -200.0% -7.66%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 18.25K $2.935M 15.66K
YoY Change -1493.13% 18640.22% -142.34%
NET CHANGE
Cash From Operating Activities -215.8K -$1.822M 211.9K
Cash From Investing Activities 10.00K $10.00K -10.00K
Cash From Financing Activities 18.25K $2.935M 15.66K
Net Change In Cash -187.6K $1.123M 217.6K
YoY Change -55.97% 416.04% -58.45%
FREE CASH FLOW
Cash From Operating Activities -$215.8K -$1.822M $211.9K
Capital Expenditures $0.00 $0.00 -$10.00K
Free Cash Flow -$215.8K -$1.822M $221.9K
YoY Change -49.18% -920.92% -61.89%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000845819
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
usd
CY2021Q4 us-gaap Loans Payable Current
LoansPayableCurrent
usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
CY2021 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
CY2022 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
usd
CY2022 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
usd
CY2021 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
usd
CY2021 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
usd
CY2021 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
usd
CY2022 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2021 us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2022 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-10171
CY2022 dei Entity Registrant Name
EntityRegistrantName
KonaTel, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
80-0973608
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
500 N. Central Expressway
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 202
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Plano
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75074
CY2022 dei City Area Code
CityAreaCode
214
CY2022 dei Local Phone Number
LocalPhoneNumber
323-8410
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
29362185 usd
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
42240406 shares
CY2022 dei Auditor Name
AuditorName
Haynie & Company
CY2022 dei Auditor Location
AuditorLocation
Salt Lake City, Utah
CY2022 dei Auditor Firm
AuditorFirmId
457
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2055634 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
932785 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1510118 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1274687 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
566839 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
61241 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
79467 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
164 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
4153494 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
2853942 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48887 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1187937 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
807775 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
73883 usd
CY2021Q4 us-gaap Other Assets
OtherAssets
154297 usd
CY2021Q4 us-gaap Investments And Other Noncurrent Assets
InvestmentsAndOtherNoncurrentAssets
10000 usd
CY2022Q4 ktel Total Other Assets
TotalOtherAssets
1261820 usd
CY2021Q4 ktel Total Other Assets
TotalOtherAssets
972072 usd
CY2022Q4 us-gaap Assets
Assets
5451850 usd
CY2021Q4 us-gaap Assets
Assets
3874901 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
1348931 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
930449 usd
CY2022Q4 us-gaap Loans Payable Current
LoansPayableCurrent
3070947 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118382 usd
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
50672 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4538260 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
981121 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458227 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
136445 usd
CY2021Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
150000 usd
CY2022Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
458227 usd
CY2021Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
286445 usd
CY2022Q4 us-gaap Liabilities
Liabilities
4996487 usd
CY2021Q4 us-gaap Liabilities
Liabilities
1267566 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
42240406 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
42240406 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
41615406 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41615406 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
42240 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
41615 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
8710987 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7911224 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8297864 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5345504 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2607335 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5451850 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3874901 usd
CY2022 us-gaap Revenues
Revenues
20023340 usd
CY2021 us-gaap Revenues
Revenues
12834844 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
15033733 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
7105464 usd
CY2022 us-gaap Gross Profit
GrossProfit
4989607 usd
CY2021 us-gaap Gross Profit
GrossProfit
5729380 usd
CY2022 us-gaap Labor And Related Expense
LaborAndRelatedExpense
4974989 usd
CY2021 us-gaap Labor And Related Expense
LaborAndRelatedExpense
2702495 usd
CY2022 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
8129 usd
CY2021 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
1887 usd
CY2022 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
29133 usd
CY2021 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
31318 usd
CY2022 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
1509269 usd
CY2021 us-gaap Professional And Contract Services Expense
ProfessionalAndContractServicesExpense
697594 usd
CY2022 us-gaap Other General Expense
OtherGeneralExpense
206380 usd
CY2021 us-gaap Other General Expense
OtherGeneralExpense
146254 usd
CY2022 us-gaap Depreciation And Amortization
DepreciationAndAmortization
12352 usd
CY2021 us-gaap Depreciation And Amortization
DepreciationAndAmortization
833016 usd
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
300042 usd
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
156386 usd
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
106402 usd
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
90635 usd
CY2022 ktel Application Development Costs
ApplicationDevelopmentCosts
146400 usd
CY2021 ktel Application Development Costs
ApplicationDevelopmentCosts
266191 usd
CY2022 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
251196 usd
CY2021 us-gaap Real Estate Taxes And Insurance
RealEstateTaxesAndInsurance
165257 usd
CY2022 us-gaap Operating Expenses
OperatingExpenses
7544292 usd
CY2021 us-gaap Operating Expenses
OperatingExpenses
5091033 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-2554685 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
638347 usd
CY2022 us-gaap Interest Expense
InterestExpense
399031 usd
CY2021 us-gaap Interest Expense
InterestExpense
15361 usd
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1356 usd
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-397675 usd
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-15361 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
622986 usd
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41863283 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40909085 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41863283 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42891011 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1532834 usd
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
110000 usd
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
341515 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
622986 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
2607335 usd
CY2022 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
108250 usd
CY2022 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
692138 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
455363 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
622986 usd
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
12352 usd
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
833016 usd
CY2022 us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
-94478 usd
CY2022 us-gaap Provision For Other Losses
ProvisionForOtherLosses
29133 usd
CY2021 us-gaap Provision For Other Losses
ProvisionForOtherLosses
31318 usd
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
692138 usd
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
341515 usd
CY2022 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
83612 usd
CY2021 ktel Change In Right Of Use Asset
ChangeInRightOfUseAsset
92947 usd
CY2022 ktel Change In Lease Liability
ChangeInLeaseLiability
92941 usd
CY2021 ktel Change In Lease Liability
ChangeInLeaseLiability
105395 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
264564 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
871204 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-40502 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
549053 usd
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-98640 usd
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
77102 usd
CY2022 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
418483 usd
CY2021 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-112117 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-37677 usd
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-17800 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1821869 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
211930 usd
CY2021 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
10000 usd
CY2022 us-gaap Proceeds From Sale Of Other Productive Assets
ProceedsFromSaleOfOtherProductiveAssets
10000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
10000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10000 usd
CY2022 us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
3150000 usd
CY2022 us-gaap Payments Of Loan Costs
PaymentsOfLoanCosts
173532 usd
CY2022 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
150000 usd
CY2021 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
94339 usd
CY2022 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
108250 usd
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
110000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2934718 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15661 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1122849 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
217591 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
932785 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
715194 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2055634 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
932785 usd
CY2022 us-gaap Interest Paid Net
InterestPaidNet
3099 usd
CY2021 us-gaap Interest Paid Net
InterestPaidNet
6796 usd
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
472974 usd
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
199245 usd
CY2021 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-0 usd
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
692138 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
526337 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2021Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0 usd
CY2022 us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Leasehold improvements are amortized over the lesser of the lease term or estimated useful life, furniture and fixtures, equipment, and vehicles are depreciated over periods ranging from five to seven (5-7) years, and billing software is depreciated over three (3) years which represents the estimated useful life of the assets.
CY2022 us-gaap Revenue Recognition Sales Of Services
RevenueRecognitionSalesOfServices
<p id="xdx_840_eus-gaap--RevenueRecognitionSalesOfServices_zyz0Eky5foD2" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i>Cost of Revenue</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Cost of Revenue includes the cost of communication services, equipment and accessories, shipping costs, and agent compensation.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><i> </i></p>
CY2021 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
341515 usd
CY2022 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
1557516 usd
CY2022Q4 ktel Collateral Deposits
CollateralDeposits
0 usd
CY2021Q4 ktel Collateral Deposits
CollateralDeposits
0 usd
CY2022Q4 ktel Operating Lease Assets And Liabilities Recorded
OperatingLeaseAssetsAndLiabilitiesRecorded
151471 usd
CY2022Q4 ktel Operating Lease Assets And Liabilities
OperatingLeaseAssetsAndLiabilities
576609 usd
CY2021Q4 ktel Operating Lease Assets And Liabilities
OperatingLeaseAssetsAndLiabilities
187117 usd
CY2022 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<p id="xdx_84F_eus-gaap--RevenueRecognitionDeferredRevenue_zjPlcIUQBkog" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Deferred Revenue</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i> </i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Services for cellular and telecommunication services have a monthly recurring charge that is billed in advance. This charge covers a thirty (30) or thirty-one (31)-day period. This charge is deferred for the period in which it was received and recorded as revenue at the conclusion of this period. Costs, mainly from outside providers, associated with the deferred revenue are recognized in the same period as revenue is recognized.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2022 us-gaap Advertising Expense
AdvertisingExpense
106402 usd
CY2021 us-gaap Advertising Expense
AdvertisingExpense
90635 usd
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1981926 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5862938 usd
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1981926 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.25
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y7M24D
CY2021Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
2970907 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
-2952360 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
622986 usd
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
41863283 shares
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
40909085 shares
CY2021 us-gaap Incremental Common Shares Attributable To Call Options And Warrants
IncrementalCommonSharesAttributableToCallOptionsAndWarrants
1981926 shares
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
41863283 shares
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
42891011 shares
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zH2FKPXpJCh9" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Concentrations of Credit Risk</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Financial instruments which potentially subject the Company to concentrations of credit risk consist primarily of receivables, cash, and cash equivalents.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">All cash and cash equivalents and restricted cash and cash equivalents are held at high credit financial institutions. These deposits are generally insured under the FDIC’s deposit insurance coverage; however, from time to time, the deposit levels may exceed FDIC coverage levels.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_914_eus-gaap--TradeAccountsReceivableMember_zmTD9pQlUB7c" style="display: none">Trade Account Receivables</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span id="xdx_91E_eus-gaap--SalesRevenueNetMember_zTd0cKulCz9l" style="display: none">Sales Revenue</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has a concentration of risk with respect to trade receivables from customers and cellular providers. As of December 31, 2022, the Company had a significant concentration of receivables (defined as customers whose receivable balances are greater than 10% of total receivables) due from two (2) customers in the amounts of $<span id="xdx_904_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zgejWu2Nqp0f" title="Concentration receivables">859,334</span> or <span id="xdx_901_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_z2xdwWanjka3" title="Concentration risk">57.0</span>% and $<span id="xdx_909_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zzIGMH78ipxe" title="Concentration receivables">255,136</span> or <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_dp_c20220101__20221231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zaHcxEK1abZ6" title="Concentration risk">16.9</span>%. As of December 31, 2021, the Company had a significant concentration of receivables from two (2) customers in the amounts of $<span id="xdx_905_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_z2Dv5zFERl9" title="Concentration receivables">783,431</span>, or <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerOneMember_zBr8g5gH7zql" title="Concentration risk">63.9</span>%, and $<span id="xdx_90C_eus-gaap--FairValueConcentrationOfRiskAccountsReceivable_iI_c20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zR6ZpowJuTj5" title="Concentration receivables">194,647</span>, or <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_dp_c20210101__20211231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--TradeAccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__custom--CustomerTwoMember_zdBRmHwkEucg" title="Concentration risk">15.9</span>%.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p>
CY2021 us-gaap Revenues
Revenues
12834844 usd
CY2021 us-gaap Gross Profit
GrossProfit
5729380 usd
CY2021 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
833016 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
461611 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
425075 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
412724 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
36536 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48887 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
173524 usd
CY2022 us-gaap Lessee Operating Lease Description
LesseeOperatingLeaseDescription
the Company had four (4) properties with lease terms in excess of one (1) year. Of these four (4) leases, two (2) leases expire in 2025, one (1) lease expires in 2026, and one (1) lease expires in 2030
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
576609 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
153593 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
155325 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
129543 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
65968 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
54000 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
144000 usd
CY2022Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
702429 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
125820 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
576609 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
118382 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
458227 usd
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P68M15D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0676 pure
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
152639 usd
CY2022Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2021Q4 us-gaap Finite Lived Customer Lists Gross
FiniteLivedCustomerListsGross
1135962 usd
CY2022Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2021Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
2407001 usd
CY2022Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2021Q4 us-gaap Finite Lived License Agreements Gross
FiniteLivedLicenseAgreementsGross
634251 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3542963 usd
CY2022Q4 ktel Net Amortizable Intangibles
NetAmortizableIntangibles
634251 usd
CY2021Q4 ktel Net Amortizable Intangibles
NetAmortizableIntangibles
634251 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
553686 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
173524 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1187937 usd
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
807775 usd
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
0 usd
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
802334 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Fair Value Disclosure
FiniteLivedIntangibleAssetsFairValueDisclosure
634251 usd
CY2021 us-gaap Income Tax Examination Description
IncomeTaxExaminationDescription
In June of 2021, the Company received an audit determination and assessment from the State of Pennsylvania related to sales and use tax for the audit period of January 1, 2016, through September 30, 2019. The assessment is in the amount of $115,000, including interest and penalties calculated on sales made inside and outside Pennsylvania. The Company has recorded the full amount of this assessment. The Company appealed the assessment in August 2021, and at the request of the state, provided additional information to support its appeal. The Company’s position is that Pennsylvania has no sales tax authority to levy and collect sales tax on sales made outside of Pennsylvania. The Company initially recorded an expected liability of $7,000, based on known sales inside Pennsylvania. The State of Pennsylvania rejected an appeal by the Company. The Company remains in discussions with the State of Pennsylvania and is working towards a plan to pay the full amount of the liability, under the possibility of an extended payout period.
CY2022 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 number
CY2022 us-gaap Revenues
Revenues
20023340 usd
CY2022 us-gaap Gross Profit
GrossProfit
4989607 usd
CY2022 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
12352 usd
CY2022 us-gaap Property Plant And Equipment Additions
PropertyPlantAndEquipmentAdditions
-0 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
1.9271 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Weighted Average Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate
2.316 pure
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y3M
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0190 pure
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0078 pure
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4260000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.37
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y3M
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
5862938 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
900000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.16
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
625000 shares
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.17
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
920750 usd
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
130000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4405000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.59
CY2022 ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P3Y2M19D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2260138 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1722041 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.36
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P1Y9M18D
CY2022Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1271653 usd
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3800000 shares
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.21
CY2021 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y7M6D
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
812350 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1635000 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.75
CY2021 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
923120 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.14
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
847406 usd
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
251880 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4260000 shares
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.37
CY2021 ktel Weighted Average Remaining Life At End Of Period
WeightedAverageRemainingLifeAtEndOfPeriod
P2Y3M
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
850050 usd
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
361947 usd
CY2022Q4 ktel Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
3716 usd
CY2021Q4 ktel Deferred Tax Assets Depreciation And Amortization
DeferredTaxAssetsDepreciationAndAmortization
24290 usd
CY2022Q4 ktel Deferred Tax Assets Stock Option Expense
DeferredTaxAssetsStockOptionExpense
324528 usd
CY2021Q4 ktel Deferred Tax Assets Stock Option Expense
DeferredTaxAssetsStockOptionExpense
172062 usd
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
1178294 usd
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
558299 usd
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-619996 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
130827 usd
CY2021 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
-31991 usd
CY2022 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
619996 usd
CY2021 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-98836 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4047861 usd
CY2022Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
4047861 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001515971-23-000048-index-headers.html Edgar Link pending
0001515971-23-000048-index.html Edgar Link pending
0001515971-23-000048.txt Edgar Link pending
0001515971-23-000048-xbrl.zip Edgar Link pending
exhibit311.htm Edgar Link pending
exhibit312.htm Edgar Link pending
exhibit32.htm Edgar Link pending
exhibit4.htm Edgar Link pending
exhibit991.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
ktel-20221231.xsd Edgar Link pending
ktel2022ye10k.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
ktel-20221231_def.xml Edgar Link unprocessable
ktel-20221231_lab.xml Edgar Link unprocessable
ktel-20221231_pre.xml Edgar Link unprocessable
ktel2022ye10k_htm.xml Edgar Link completed
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ktel-20221231_cal.xml Edgar Link unprocessable